NDC 82804-086 – Emtricitabine and tenofovir disoproxil fumarate

Emtricitabine 200 mg/1; Tenofovir Disoproxil Fumarate 300 mg/1 · Tablet, Film Coated · Oral

Human Prescription Drug

Product NDC82804-086

Product details

Brand name
Emtricitabine and tenofovir disoproxil fumarate
Generic name
Emtricitabine and tenofovir disoproxil fumarate
Labeler
Proficient Rx LP
Dosage form
Tablet, Film Coated
Route
Oral
Marketing category
ANDA · ANDA201806
Marketed since
October 7, 2021
Listing expires
December 31, 2027
Pharmacologic class
Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor

Active ingredients

Uses, dosage, side effects and warnings for Emtricitabine and tenofovir disoproxil fumarate →

Package NDC codes (2)

Package NDCDescriptionSince
82804-086-033 TABLET, FILM COATED in 1 BOTTLE (82804-086-03)Feb 16, 2026
82804-086-077 TABLET, FILM COATED in 1 BOTTLE (82804-086-07)Feb 16, 2026

Other Emtricitabine and tenofovir disoproxil fumarate products